静脉支架置入治疗下肢慢性血栓性静脉阻塞的有效性
回顾性分析2019年5月至2021年4月在Al-Azhar大学医院收治的63例症状性髂股静脉血栓性闭塞并接受静脉支架置入患者的病历,技术成功率88.9%,12个月一期、辅助一期和二期通畅率分别为76.8%、80.4%和87.5%,2年分别为73.2%、80.4%和87.5%,并发症率6.3%,无手术相关死亡。作者认为该方法是有效安全的,应考虑作为症状性髂股静脉闭塞的一线治疗。
要点
- 63例症状性髂股静脉血栓性闭塞患者接受静脉支架置入,技术成功率为88.9%。
- 12个月一期、辅助一期和二期通畅率分别为76.8%、80.4%和87.5%。
- 2年一期、辅助一期和二期通畅率分别为73.2%、80.4%和87.5%。
核心结论
- 球囊血管成形术联合支架置入的血管内治疗是治疗慢性静脉血栓性闭塞的有效且安全的方法,具有较高的技术成功率和优良的通畅率。
- 作者认为,该方法应被视为症状性髂股静脉闭塞的一线治疗。
研究设计与样本
- 回顾性病历审查,纳入2019年5月至2021年4月在Al-Azhar大学医院诊断为症状性髂股静脉血栓性闭塞并接受静脉支架置入治疗的63例患者。
- 63例中44例为女性,中位年龄49.52岁。
主要发现
- 技术成功(optimal success)获得于56例(88.9%)。
- 12个月一期通畅率为76.8%,辅助一期通畅率为80.4%,二期通畅率为87.5%。
- 2年一期通畅率为73.2%,辅助一期通畅率为80.4%,二期通畅率为87.5%。
- 手术相关并发症发生率为6.3%;穿刺部位血肿2例(3.2%),早期(30天)支架内血栓形成2例(3.2%)。
- 无手术相关死亡。
临床怎么用
- 作者认为,球囊血管成形术联合支架置入的血管内治疗应被视为症状性髂股静脉闭塞的一线治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with venous hypertension (HTN) have significant morbidity and poor quality of life. Deep venous thrombosis (DVT) and congenital defects that led to chronic outflow blockage are frequent causes of venous HTN. It is known that the venovenous bypass has been the standard method used in the treatment of chronic iliofemoral vein occlusions. Percutaneous recanalization has earlier been shown to be technically possible. With venoplasty and stenting, we used an aggressive endovascular strategy to treat the iliofemoral venous thrombotic occlusion. METHODS: From May 2019 to April 2021, the medical records were reviewed for 63 patients diagnosed with symptomatic iliofemoral thrombotic occlusive disease and treated with venous stenting. The procedures' results were analyzed at Al-Azhar University Hospitals. RESULTS: The medical records of 63 cases (44 women with a median age of 49.52 years), with chronic outflow block of iliofemoral vein segment that were treated with endovascular venous stenting, were reviewed retrospectively. Optimal success was obtained in 56 cases (88.9%). The twelve-month primary, assisted primary, and secondary patency rates were 76.8%, 80.4%, and 87.5%, respectively, while it was 73.2%, 80.4%, and 87.5%, respectively, after 2 years. The procedure-related complication rate was 6.3%. Puncture site hematoma was observed in 2 patients (3.2%). Early (30 days) stent thrombosis occurred in 2 patients (3.2%). Most importantly, there was no procedure-related mortality. CONCLUSIONS: Endovascular treatment with balloon angioplasty and stenting of chronic venous thrombotic occlusions is an effective and safe procedure associated with a high technical rate of success and excellent patency rates. Accordingly, it should be considered the first line in the treatment of symptomatic iliofemoral vein occlusion.
引用
- Elshinawy WE, Abdo EM, Farouk N, et al. Effectiveness of Venous Stenting for the Treatment of Lower Extremity Chronic Thrombotic Venous Obstruction. Ann Vasc Surg. 2022. PMID: 36581155. doi:10.1016/j.avsg.2022.12.084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。